Join
Live feed
·
INSIDERFilingvia Quantisnow
Merus N.V. logo

Large owner Genmab A/S bought $26,340,059 worth of shares (271,547 units at $97.00) (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
MRUS· Merus N.V.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MRUS (Merus N.V.) and more on Quantisnow.